Birmingham Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.85M | Hold |
23,240
| – | – | 2.22% | 12 |
|
|
2026
Q1 | $5.05M | Sell |
23,240
-875
| -4% | -$194K | 2.13% | 13 |
|
|
2025
Q4 | $5.51M | Sell |
24,115
-75
| -0.3% | -$17.1K | 2.43% | 12 |
|
|
2025
Q3 | $5.6M | Sell |
24,190
-1,600
| -6% | -$326K | 2.57% | 11 |
|
|
2025
Q2 | $4.79M | Sell |
25,790
-4,757
| -16% | -$884K | 2.12% | 14 |
|
|
2025
Q1 | $6.4M | Hold |
30,547
| – | – | 2.41% | 12 |
|
|
2024
Q4 | $5.43M | Sell |
30,547
-75
| -0.2% | -$13.8K | 2.01% | 16 |
|
|
2024
Q3 | $6.05M | Buy |
30,622
+900
| +3% | +$168K | 2.2% | 16 |
|
|
2024
Q2 | $5.1M | Hold |
29,722
| – | – | 1.99% | 18 |
|
|
2024
Q1 | $5.41M | Sell |
29,722
-600
| -2% | -$103K | 1.99% | 18 |
|
|
2023
Q4 | $4.7M | Sell |
30,322
-80
| -0.3% | -$11.7K | 1.86% | 18 |
|
|
2023
Q3 | $4.53M | Buy |
30,402
+725
| +2% | +$106K | 1.87% | 18 |
|
|
2023
Q2 | $4M | Sell |
29,677
-1,323
| -4% | -$194K | 1.67% | 20 |
|
|
2023
Q1 | $4.94M | Buy |
31,000
+20
| +0.1% | +$3.06K | 1.97% | 18 |
|
|
2022
Q4 | $5.01M | Hold |
30,980
| – | – | 1.9% | 19 |
|
|
2022
Q3 | $4.16M | Buy |
30,980
+500
| +2% | +$71.7K | 1.84% | 20 |
|
|
2022
Q2 | $4.67M | Hold |
30,480
| – | – | 1.86% | 21 |
|
|
2022
Q1 | $4.94M | Sell |
30,480
-750
| -2% | -$109K | 1.72% | 19 |
|
|
2021
Q4 | $4.23M | Hold |
31,230
| – | – | 1.53% | 24 |
|
|
2021
Q3 | $3.37M | Sell |
31,230
-800
| -2% | -$91.4K | 1.29% | 28 |
|
|
2021
Q2 | $3.61M | Hold |
32,030
| – | – | 1.32% | 27 |
|
|
2021
Q1 | $3.47M | Sell |
32,030
-200
| -0.6% | -$21.4K | 1.3% | 28 |
|
|
2020
Q4 | $3.45M | Buy |
32,230
+1,040
| +3% | +$99.9K | 1.43% | 26 |
|
|
2020
Q3 | $2.73M | Buy |
31,190
+1,360
| +5% | +$128K | 1.24% | 30 |
|
|
2020
Q2 | $2.93M | Buy |
29,830
+550
| +2% | +$48.4K | 1.43% | 25 |
|
|
2020
Q1 | $2.23M | Sell |
29,280
-1,000
| -3% | -$85.2K | 1.23% | 27 |
|
|
2019
Q4 | $2.68M | Sell |
30,280
-850
| -3% | -$70.6K | 1.19% | 28 |
|
|
2019
Q3 | $2.36M | Buy |
31,130
+1,900
| +7% | +$130K | 1.09% | 34 |
|
|
2019
Q2 | $2.13M | Buy |
29,230
+60
| +0.2% | +$4.72K | 0.96% | 36 |
|
|
2019
Q1 | $2.35M | Buy |
29,170
+1,350
| +5% | +$110K | 1.05% | 35 |
|
|
2018
Q4 | $2.56M | Buy |
27,820
+172
| +0.6% | +$15.1K | 1.25% | 30 |
|
|
2018
Q3 | $2.62M | Hold |
27,648
| – | – | 1.08% | 35 |
|
|
2018
Q2 | $2.56M | Hold |
27,648
| – | – | 1.1% | 36 |
|
|
2018
Q1 | $2.62M | Sell |
27,648
-300
| -1% | -$33K | 1.09% | 35 |
|
|
2017
Q4 | $2.7M | Sell |
27,948
-100
| -0.4% | -$9.43K | 1.03% | 34 |
|
|
2017
Q3 | $2.49M | Hold |
28,048
| – | – | 0.99% | 35 |
|
|
2017
Q2 | $2.03M | Sell |
28,048
-800
| -3% | -$53.8K | 0.82% | 44 |
|
|
2017
Q1 | $1.88M | Buy |
28,848
+380
| +1% | +$23.9K | 0.76% | 44 |
|
|
2016
Q4 | $1.78M | Hold |
28,468
| – | – | 0.75% | 44 |
|
|
2016
Q3 | $1.76M | Sell |
28,468
-135
| -0.5% | -$8.74K | 0.78% | 41 |
|
|
2016
Q2 | $1.77M | Hold |
28,603
| – | – | 0.78% | 41 |
|
|
2016
Q1 | $1.63M | Sell |
28,603
-100
| -0.3% | -$5.57K | 0.66% | 46 |
|
|
2015
Q4 | $1.7M | Hold |
28,703
| – | – | 0.69% | 47 |
|
|
2015
Q3 | $1.56M | Sell |
28,703
-750
| -3% | -$48.8K | 0.68% | 49 |
|
|
2015
Q2 | $1.98M | Sell |
29,453
-150
| -0.5% | -$9.79K | 0.77% | 45 |
|
|
2015
Q1 | $1.73M | Buy |
29,603
+140
| +0.5% | +$8.46K | 0.66% | 52 |
|
|
2014
Q4 | $1.93M | Hold |
29,463
| – | – | 0.74% | 45 |
|
|
2014
Q3 | $1.7M | Sell |
29,463
-600
| -2% | -$33.3K | 0.65% | 52 |
|
|
2014
Q2 | $1.7M | Sell |
30,063
-430
| -1% | -$22.6K | 0.62% | 49 |
|
|
2014
Q1 | $1.57M | Sell |
30,493
-112
| -0.4% | -$5.66K | 0.59% | 52 |
|
|
2013
Q4 | $1.62M | Sell |
30,605
-675
| -2% | -$33.2K | 0.61% | 53 |
|
|
2013
Q3 | $1.4M | Sell |
31,280
-3,800
| -11% | -$168K | 0.55% | 56 |
|
|
2013
Q2 | $1.45M | Buy |
+35,080
| New | +$1.53M | 0.6% | 55 |
|
Other funds holding ABBV
Birmingham Capital Management's ABBV Position: Q2 2026 in Review
Birmingham Capital Management held its AbbVie (ABBV) position steady in Q2 2026 at 23,240 shares worth $5.85M. The position accounts for 2.22% of the portfolio, ranked #12.
Birmingham Capital Management first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. The position peaked at $6.4M in Q1 2025. 4,191 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Birmingham Capital Management held 23,240 shares of AbbVie worth $5.85M as of Q2 2026.
- Birmingham Capital Management left its AbbVie share count unchanged in Q2 2026.
- AbbVie made up 2.22% of Birmingham Capital Management's portfolio in Q2 2026, its #12 holding.
- Birmingham Capital Management first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
- Birmingham Capital Management's AbbVie position peaked at $6.4M in Q1 2025.
- 4,191 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Birmingham Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.